Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
This piece examines Which Sp 500 Fund Grew Most In 2024 Retirement, focusing on growth drivers, expense ratios, and suitability for retirement accounts.
25,898 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
The U.S. economy grew at a 2.0% annualized rate in Q1, powered by AI-related investment and resilient consumer spendi...
Realty Income anchors retiree portfolios with a steady 5.3% yield, supported by robust AFFO coverage and a resilient ...
Investors turn to a resilient, income-focused mix to weather headlines and market swings in 2026. A practical framewo...
NVIDIA's quarterly results come as tech stocks swing, with investors assessing data center demand, margins, and AI ec...
Investors eyeing DEI in 2026 should study the Q1 results, leverage, and lease metrics that shape the office REIT's tr...
A veteran investor argues Talen Energy is undervalued versus its replacement cost, with potential for a doubling or m...
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
A Bay Area city mayor emerges as the lone pragmatic Democrat in California's governor race, drawing tech money and sp...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
A focused look at a nuclear energy stock with small modular reactors (SMRs) at the center. Learn the potential upside...
President Donald Trump plans up to four in-person talks with Xi Jinping within eight months as Air Force One heads to...